We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BMEA market cap is 439.18M. The company's latest EPS is USD -3.2839 and P/E is -3.75.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -23.48M | -26.28M | -30.03M | -27.66M | -31.12M |
| Net Income | -22.89M | -25.31M | -29.05M | -24.89M | -28.43M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.2M | -5.33M | -41.67M | -83.63M | -126.14M |
| Net Income | -1.2M | -5.32M | -41.57M | -81.83M | -117.26M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 145.05M | 129.31M | 112.64M | 248.67M | 225.09M |
| Total Liabilities | 14.42M | 20.77M | 29.51M | 24.37M | 25.48M |
| Total Equity | 130.64M | 108.54M | 83.13M | 224.31M | 199.61M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 265k | 62.53M | 185.71M | 129.31M | 199.93M |
| Total Liabilities | 286k | 1.62M | 6.92M | 20.77M | 30.69M |
| Total Equity | -21k | 5.17M | 178.78M | 108.54M | 169.24M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -42.22M | -62.42M | -24.04M | -49.86M | -73.76M |
| Investing | 28.04M | 27.34M | -1.76M | -2.17M | -2.21M |
| Financing | 749k | 1.24M | 201k | 163.04M | 163.18M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.28M | -4.46M | -35.44M | -62.42M | -96.59M |
| Investing | N/A | -51k | -33.36M | 27.34M | -2.22M |
| Financing | 1.44M | 65.97M | 153.19M | 1.24M | 163.8M |
| Market Cap | 439.18M |
| Price to Earnings Ratio | -3.75 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.49 |
| Price to Book Ratio | 2.6 |
| Dividend Yield | - |
| Shares Outstanding | 35.71M |
| Average Volume (1 week) | 712.99k |
| Average Volume (1 Month) | 830.95k |
| 52 Week Change | -58.86% |
| 52 Week High | 43.69 |
| 52 Week Low | 8.125 |
| Spread (Intraday) | 1.27 (9.43%) |
| Company Name | Biomea Fusion Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.biomeafusion.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
